Telomir Pharmaceuticals TELO
NASDAQ TELO
$1.02 +0.01 (+0.99%)
At close: Oct 21, 2026 · 4:00 PM EDT

Telomir Pharmaceuticals (TELO) Interest Expenses (2023 - 2026)

Updated

Telomir Pharmaceuticals (TELO) posted Interest Expenses of $3,028 for Q2 2026, up 125.6% from $1,342 a year earlier.

Analysis

Telomir Pharmaceuticals (TELO) Interest Expenses (2023 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Interest Expenses at Telomir Pharmaceuticals was $4,369, up 225.8% year-over-year; for FY2024, it came in at $4.34 million, up 164.1% from FY2023.

  • In prior years, Telomir Pharmaceuticals' Interest Expenses was $1.64 million in FY2023.
  • The Q2 2026 figure stands as the highest quarterly Interest Expenses since Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 281.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 462.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 435.00 Mn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 247.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Telomir Pharmaceuticals 62.66 Mn 42.09 Mn - 3,028.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3,028.00
Jun 30, 2025 1,342.00
Dec 31, 2024 -1.00
Sep 30, 2024 1.00
Jun 30, 2024 -1.00
Mar 31, 2024 4.34 Mn
Dec 31, 2023 761,824.00
Sep 30, 2023 757,173.00
Jun 30, 2023 124,052.00
API Access

Telomir Pharmaceuticals Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=TELO&period=max&api_key=YOUR_API_KEY